Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its and partner Sandoz's favour over the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.

LONDON (MarketWatch) -- Lung-disease patients taking GlaxoSmithKline PLC's GSK asthma inhaler Seretide have better survival benefits than those taking a rival product, according to a study published ...

Asthma UK said that "faulty inhalers could put people's lives at risk" as it called on patients to check whether their inhaler needed to be returned. The call comes after the Medicines and Healthcare ...

Faulty inhalers could be putting thousands of lives at risk as an urgent recall has been issued. Two different brands of inhalers have been recalled over fears they not be correctly delivering ...